Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02952742
What this trial is testing

Black Cohosh for Host Flashes Due to Androgen Deprivation Therapy

Who this might be right for
Hot Flashes
Midwestern Regional Medical Center
Testing effectiveness (Phase 2)Study completedNCT03543670
What this trial is testing

Evaluation of Oncoxin-Viusid® in Prostate Cancer

Who this might be right for
Prostate Cancer
Catalysis SL 25
Large-scale testing (Phase 3)Active Not RecruitingNCT00430183
What this trial is testing

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 788
Not applicableLooking for participantsNCT07553754
What this trial is testing

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Who this might be right for
Prostate Cancer (Diagnosis)Bone MetastasisPSMA PET+4 more
Xijing Hospital 1,000
Not applicableStudy completedNCT01804231
What this trial is testing

Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 22
Not applicableUnknownNCT06034431
What this trial is testing

Increasing Access to Definitive Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
Brigham and Women's Hospital 150
Early research (Phase 1)Study completedNCT05868057
What this trial is testing

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Who this might be right for
Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
Jiangsu HengRui Medicine Co., Ltd. 16
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Looking for participantsNCT05417594
What this trial is testing

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 695
Not applicableUnknownNCT03770351
What this trial is testing

Early Prostate Cancer: Predicting Treatment Response

Who this might be right for
Prostate Cancer
University of California, Irvine 693
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Testing effectiveness (Phase 2)Study completedNCT00915122
What this trial is testing

Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University Health Network, Toronto 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960022
What this trial is testing

Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 900
Large-scale testing (Phase 3)Study completedNCT03295565
What this trial is testing

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer MetastaticMetastasis
The Netherlands Cancer Institute 100
Early research (Phase 1)Study completedNCT03412786
What this trial is testing

Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases

Who this might be right for
Prostate Cancer
Herlev Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT02906605
What this trial is testing

The Clinical Activity and Safety of JNJ-64041809, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Apalutamide Versus Apalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Janssen Research & Development, LLC
Not applicableEnded earlyNCT04960956
What this trial is testing

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

Who this might be right for
Prostate CancerUrothelial Carcinoma
Indiana University 13
Post-approval studies (Phase 4)Temporarily pausedNCT06226129
What this trial is testing

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Who this might be right for
Prostate Cancer
Columbia University 150
Testing effectiveness (Phase 2)Study completedNCT00547339
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 94
Not applicableStudy completedNCT04685928
What this trial is testing

Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 403
Next Page